EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells

Nataly Peres, Guilherme A Lepski iD, Carla S Fogolin iD, Gabriela C M Evangelista iD, Elizabeth A Flatow, Jaqueline V de Oliveira iD, Mariana P Pinho iD, Patricia C Bergami-Santos, José A M Barbuto iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nataly Peres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Medical School, Universidade de Sao Paulo, Sao Paulo 05403-010, Brazil. Hauptthemen laut MEDLINE: Dendritic Cells, Glioblastoma, Immunotherapy, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Faculdade de Medicina, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundaçao Faculdade de Medicina, Universidade de Sao Paulo, Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastomas (GBM) are the most common primary malignant brain tumors, comprising 2% of all cancers in adults. Their location and cellular and molecular heterogeneity, along with their highly infiltrative nature, make their treatment challenging. Recently, our research group reported promising results from a prospective phase II clinical trial involving allogeneic vaccination with dendritic cells (DCs). To date, six out of the thirty-seven reported cases remain alive without tumor recurrence. In this study, we focused on the characterization of infiltrating immune cells observed at the time of surgical resection. An analytical model employing a neural network-based predictive algorithm was used to ascertain the potential prognostic implications of immunological variables on patients’ overall survival. Counterintuitively, immune phenotyping of tumor-associated macrophages (TAMs) has revealed the extracellular marker PD-L1 to be a positive predictor of overall survival. In contrast, the elevated expression of CD86 within this cellular subset emerged as a negative prognostic indicator. Fundamentally, the neural network algorithm outlined here allows a prediction of the responsiveness of patients undergoing dendritic cell vaccination in terms of overall survival based on clinical parameters and the profile of infiltrated TAMs observed at the time of tumor excision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsGlioblastomaImmunotherapyBrain NeoplasmsHumansMaleFemaleMiddle AgedB7-H1 AntigenPrognosisAdultTumor-Associated MacrophagesAgedLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

CD86PD-L1dendritic cellsglioblastomaimmunotherapypatient survivaltumor infiltratetumor microenvironment

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, Medical School, Universidade de Sao Paulo, Sao Paulo 05403-010, Brazil.
  • LIM 26, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-000, Brazil.
  • Department of Neurosurgery, Eberhard-Karls University, 72074 Tuebingen, Germany.
  • Department of Immunology, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo 05508-000, Brazil.
  • Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao…

ORCID-Profile: Guilherme A Lepski, Carla S Fogolin, Gabriela C M Evangelista, Jaqueline V de Oliveira, Mariana P Pinho, José A M Barbuto

Förderung

  • Fundação Faculdade de Medicina
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundaçao Faculdade de Medicina, Universidade de Sao Paulo, Brazil
  • Coordination for the Improvement of Higher Education Personnel—CAPES

Zitieren

APA

Peres, N., Lepski, G. A., Fogolin, C. S., Evangelista, G. C. M., Flatow, E. A., de Oliveira, J. V., Pinho, M. P., Bergami-Santos, P. C., & Barbuto, J. A. M. (2024). Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105275

Vancouver

Peres N, Lepski GA, Fogolin CS, Evangelista GCM, Flatow EA, de Oliveira JV, et al. Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105275

BibTeX
@article{Peres2024,
  author = {Peres, Nataly and Lepski, Guilherme A and Fogolin, Carla S and Evangelista, Gabriela C M and Flatow, Elizabeth A and de Oliveira, Jaqueline V and Pinho, Mariana P and Bergami-Santos, Patricia C and Barbuto, José A M},
  title = {Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105275}
}
Kostenlos starten →